Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 26, 2019

SELL
$23.15 - $28.34 $358,825 - $439,270
-15,500 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$22.03 - $32.01 $15,421 - $22,407
-700 Reduced 4.32%
15,500 $402,000
Q3 2018

Oct 29, 2018

SELL
$30.0 - $40.85 $33,000 - $44,935
-1,100 Reduced 6.36%
16,200 $513,000
Q2 2018

Jul 26, 2018

SELL
$26.4 - $42.0 $237,600 - $378,000
-9,000 Reduced 34.22%
17,300 $672,000
Q1 2018

Apr 27, 2018

BUY
$18.43 - $28.8 $484,709 - $757,440
26,300 New
26,300 $726,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.